442P Menopausal status may derive in different second-line treatment benefits in breast cancer patients that experienced disease progression with CDK4/6 inhibitors (SUMA-001)
| Autor: | Waisberg, F.D., Mando, P., Almada, C., Kassis, N., Mainella, A.C., Cermignani, L., Riggi, M.C., Winocur, M., Guercovich, A., Ayala, N.C., Micheri, C., Ituarte, A.C., Gonzalez Mattos, L., Lludgar, P., Casalnuovo, M.L., Lutteral, M.A., Cinquini, S., Gomez-Abuin, G. |
|---|---|
| Zdroj: | In Annals of Oncology October 2023 34 Supplement 2:S367-S367 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|